141
Views
0
CrossRef citations to date
0
Altmetric
General content - Editorial

Ten-Gene Biomarker Panel: a New Hope for Ovarian Cancer?

&
Pages 523-526 | Published online: 06 May 2014

References

  • Paik S , ShakS , TangGet al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N. Engl. J. Med. 351 , 2817 – 2826 ( 2004 ).
  • van de VijverMJ , HeYD , van’tVeer LJet al.A gene expression signature as a predictor of survival in breast cancer.N. Engl. J. Med.347 , 1999 – 2009 ( 2002 ).
  • Cheon DJ , TongY , SimMS , A collagen-remodeling gene signature regulated by TGFβ signaling is associated with metastasis and poor survival in serous ovarian cancer.Clin. Cancer Res. ( 20 ( 3 ), 711–723 ( 2013 ).
  • Cancer Genome Atlas Research Network . Integrated genomic analyses of ovarian carcinoma.Nature474 , 609 – 615 ( 2011 ).
  • Bonome T , LevineDA , ShihJet al. A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer. Cancer Res. 68 , 5478 – 5486 ( 2008 ).
  • Karlan BY , DeringJ , WalshCet al. POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer . Gynecol. Oncol.132 ( 2 ),  334–342 ( 2013 ).
  • Wu YH , ChangTH , HuangYF , HuangHD , ChouCY. COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.Oncogene doi:10.1038/onc.307 ( 2013 ) ( Epub ahead of print).
  • Ween MP , HummitzschK , RodgersRJ , OehlerMK , RicciardelliC. Versican induces a pro-metastatic ovarian cancer cell behavior which can be inhibited by small hyaluronan oligosaccharides.Clin. Exp. Metastasis28 ( 2 ), 113 – 125 ( 2011 ).
  • Chen JL , EspinosaI , LinAY , LiaoOY , vande Rijn M , WestRB. Stromal responses among common carcinomas correlated with clinicopathologic features.Clin. Cancer Res.19 , 5127 – 5135 ( 2013 ).
  • Kim H , WatkinsonJ , VaradanV , AnastassiouD. Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1.BMC Med. Genomics3 , 51 ( 2010 ).
  • Farmer P , BonnefoiH , AnderlePet al. A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nat. Med. 15 ( 1 ), 68 – 74 ( 2009 ).
  • Wikberg ML , EdinS , LundbergIVet al. High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis. Tumour Biol. 34 ( 2 ), 1013 – 1020 ( 2013 ).
  • Wilgus ML , BorczukAC , StooplerMet al. Lysyl oxidase: a lung adenocarcinoma biomarker of invasion and survival. Cancer 117 ( 10 ), 2186 – 2191 ( 2011 ).
  • Egeblad M , NakasoneES , WerbZ. Tumors as organs: complex tissues that interface with the entire organism.Dev. Cell18 , 884 – 901 ( 2010 ).
  • Egeblad M , RaschMG , WeaverVM. Dynamic interplay between the collagen scaffold and tumor evolution.Curr. Opin Cell Biol.22 ( 5 ), 697 – 706 ( 2010 ).
  • Malanchi I , Santamaria-MartínezA , SusantoEet al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 481 ( 7379 ), 85 – 89 ( 2011 ).
  • Zhu M , SaxtonRE , RamosLet al. Neutralizing monoclonal antibody to periostin inhibits ovarian tumor growth and metastasis. Mol. Cancer Ther. 10 ( 8 ), 1500 – 1508 ( 2011 ).
  • Barker HE , CoxTR , ErlerJT. The rationale for targeting the LOX family in cancer.Nat. Rev. Cancer12 ( 8 ), 540 – 552 ( 2012 ).
  • Bondareva A , DowneyCM , AyresFet al. The lysyl oxidase inhibitor, beta-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cells . PLoS ONE4 ( 5 ), e5620 ( 2009 ).
  • Cheon D , OrsulicS. Mouse models of cancer.Annu. Rev. Pathol.6 , 95 – 119 ( 2011 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.